Literature DB >> 26318247

Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.

Jason R Wilson1, Zhu Guo1, Wen-Pin Tzeng1, Rebecca J Garten1, Xu Xiyan1, Elisabeth G Blanchard1, Kristy Blanchfield1, James Stevens1, Jacqueline M Katz1, Ian A York2.   

Abstract

Here we define the epitopes on HA that are targeted by a group of 9 recombinant monoclonal antibodies (rmAbs) isolated from memory B cells of mice, immunized by infection with A(H1N1)pdm09 virus followed by a seasonal TIV boost. These rmAbs were all reactive against the HA1 region of HA, but display 7 distinct binding footprints, targeting each of the 4 known antigenic sites. Although the rmAbs were not broadly cross-reactive, a group showed subtype-specific cross-reactivity with the HA of A/South Carolina/1/18. Screening these rmAbs with a panel of human A(H1N1)pdm09 virus isolates indicated that naturally-occurring changes in HA could reduce rmAb binding, HI activity, and/or virus neutralization activity by rmAb, without showing changes in recognition by polyclonal antiserum. In some instances, virus neutralization was lost while both ELISA binding and HI activity were retained, demonstrating a discordance between the two serological assays traditionally used to detect antigenic drift. Published by Elsevier Inc.

Entities:  

Keywords:  A/H1N1/pdm09; Antigenic drift; Antigenic site; Epitope mapping; Influenza; Monoclonal antibody; Virus neutralization

Mesh:

Substances:

Year:  2015        PMID: 26318247      PMCID: PMC5737639          DOI: 10.1016/j.virol.2015.08.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  An antibody that prevents the hemagglutinin low pH fusogenic transition.

Authors:  C Barbey-Martin; B Gigant; T Bizebard; L J Calder; S A Wharton; J J Skehel; M Knossow
Journal:  Virology       Date:  2002-03-01       Impact factor: 3.616

Review 2.  Correlates of vaccine protection from influenza and its complications.

Authors:  Jonathan A McCullers; Victor C Huber
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

3.  Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.

Authors:  Minsun Hong; Peter S Lee; Ryan M B Hoffman; Xueyong Zhu; Jens C Krause; Nick S Laursen; Sung-Il Yoon; Langzhou Song; Lynda Tussey; James E Crowe; Andrew B Ward; Ian A Wilson
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.

Authors:  Yoko Matsuzaki; Kanetsu Sugawara; Mina Nakauchi; Yoshimasa Takahashi; Taishi Onodera; Yasuko Tsunetsugu-Yokota; Takayuki Matsumura; Manabu Ato; Kazuo Kobayashi; Yoshitaka Shimotai; Katsumi Mizuta; Seiji Hongo; Masato Tashiro; Eri Nobusawa
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.

Authors:  Yoshitaka Iba; Yoshifumi Fujii; Nobuko Ohshima; Tomomi Sumida; Ritsuko Kubota-Koketsu; Mariko Ikeda; Motoaki Wakiyama; Mikako Shirouzu; Jun Okada; Yoshinobu Okuno; Yoshikazu Kurosawa; Shigeyuki Yokoyama
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

6.  A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.

Authors:  Björn F Koel; Ramona Mögling; Salin Chutinimitkul; Pieter L Fraaij; David F Burke; Stefan van der Vliet; Emmie de Wit; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Derek J Smith; Ron A M Fouchier; Miranda de Graaf
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

8.  Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

Authors:  Björn F Koel; David F Burke; Theo M Bestebroer; Stefan van der Vliet; Gerben C M Zondag; Gaby Vervaet; Eugene Skepner; Nicola S Lewis; Monique I J Spronken; Colin A Russell; Mikhail Y Eropkin; Aeron C Hurt; Ian G Barr; Jan C de Jong; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

9.  Epitope mapping of the 2009 pandemic and the A/Brisbane/59/2007 seasonal (H1N1) influenza virus haemagglutinins using mAbs and escape mutants.

Authors:  Miguel Retamal; Yacine Abed; Jacques Corbeil; Guy Boivin
Journal:  J Gen Virol       Date:  2014-07-30       Impact factor: 3.891

10.  Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.

Authors:  Weibin Hu; Aizhong Chen; Yi Miao; Shengli Xia; Zhiyang Ling; Ke Xu; Tongyan Wang; Ying Xu; Jun Cui; Hongqiang Wu; Guiyu Hu; Lin Tian; Lingling Wang; Yuelong Shu; Xiaowei Ma; Bianli Xu; Jin Zhang; Xiaojun Lin; Chao Bian; Bing Sun
Journal:  Virology       Date:  2012-10-16       Impact factor: 3.616

View more
  8 in total

Review 1.  Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.

Authors:  Zhu Guo; Jason R Wilson; Ian A York; James Stevens
Journal:  J Immunol Methods       Date:  2018-07-24       Impact factor: 2.303

2.  A(H1N1)pdm09 influenza infection: vaccine inefficiency.

Authors:  Nehemya Friedman; Yaron Drori; Rakefet Pando; Aharona Glatman-Freedman; Hanna Sefty; Ravit Bassal; Yaniv Stein; Tamy Shohat; Ella Mendelson; Musa Hindiyeh; Michal Mandelboim
Journal:  Oncotarget       Date:  2017-05-16

3.  Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo.

Authors:  Amy K F Davis; Kevin McCormick; Megan E Gumina; Joshua G Petrie; Emily T Martin; Katherine S Xue; Jesse D Bloom; Arnold S Monto; Frederic D Bushman; Scott E Hensley
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

4.  An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.

Authors:  Jason R Wilson; Zhu Guo; Adrian Reber; Ram P Kamal; Nedzad Music; Shane Gansebom; Yaohui Bai; Min Levine; Paul Carney; Wen-Pin Tzeng; James Stevens; Ian A York
Journal:  Antiviral Res       Date:  2016-10-03       Impact factor: 5.970

5.  Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans.

Authors:  Weimin Zhong; Feng Liu; Jason R Wilson; Crystal Holiday; Zhu-Nan Li; Yaohui Bai; Wen-Pin Tzeng; James Stevens; Ian A York; Min Z Levine
Journal:  Open Forum Infect Dis       Date:  2016-05-18       Impact factor: 3.835

6.  Identification and analysis of B cell epitopes of hemagglutinin of H1N1 influenza virus.

Authors:  Qing Feng; Xiao-Yan Huang; Yang-Meng Feng; Li-Jun Sun; Jing-Ying Sun; Yan Li; Xin Xie; Jun Hu; Chun-Yan Guo
Journal:  Arch Microbiol       Date:  2022-09-02       Impact factor: 2.667

7.  Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.

Authors:  Ram P Kamal; Kristy Blanchfield; Jessica A Belser; Nedzad Music; Wen-Pin Tzeng; Crystal Holiday; Ashley Burroughs; Xiangjie Sun; Taronna R Maines; Min Z Levine; Ian A York
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

8.  Genetic characterisation of the influenza viruses circulating in Bulgaria during the 2019-2020 winter season.

Authors:  Neli Korsun; Ivelina Trifonova; Silvia Voleva; Iliyana Grigorova; Svetla Angelova
Journal:  Virus Genes       Date:  2021-06-22       Impact factor: 2.332

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.